Top

Published in:

Open Access 01-03-2019 | Review Article

The transition from transesophageal to transthoracic echocardiography during transcatheter aortic valve replacement: an evolving field

Authors: Menhel Kinno, Eric P. Cantey, Vera H. Rigolin

Published in: Journal of Echocardiography | Issue 1/2019

Abstract

The advent of transcatheter aortic valve replacement (TAVR) has dramatically transformed the clinical approach to severe aortic stenosis. Over the last decade, several trials have shown the equivalence or even superiority of transcatheter valve replacement over the conventional surgical approach. As a result, TAVR as a treatment for severe, symptomatic aortic stenosis has rapidly extended from inoperable or prohibited-risk patients to intermediate-risk patients. The success of TAVR has led to the wide adaptation of this technique and, subsequently, a significant increase in the number of these procedures performed annually. As the number of these procedures is expected to further increase, especially if its indication will include those with low surgical risk, there is a great demand to improve patient recovery and early discharge without compromising outcomes. In this review, we will discuss the role of echocardiography in the perioperative planning and assessment of transcatheter aortic valve replacement. In addition, we will review the current evidence behind the use of intraprocedureal transthoracic echocardiography and the recommended steps for successful transition from transesophageal to transthoracic echocardiography.

Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.CrossRefPubMed

Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.CrossRef

Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696–704.CrossRefPubMed

Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.CrossRefPubMed

Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70:252–89.CrossRefPubMed

Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.CrossRef

Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.CrossRefPubMed

Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31.CrossRef

Grover FL, Vemulapalli S, Carroll JD, et al. 2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. J Am Coll Cardiol. 2017;69:1215–30.CrossRefPubMed

10.

Holmes DR Jr, Nishimura RA, Grover FL, et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry. Ann Thorac Surg. 2016;101:789–800.CrossRefPubMed

11.

Thyregod HG, Steinbruchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–94.CrossRefPubMed

12.

Gurevich S, Oestreich B, Kelly RF, et al. Outcomes of transcatheter aortic valve replacement using a minimalist approach. Cardiovasc Revasc Med. 2018;19:192–5.CrossRefPubMed

13.

Babaliaros V, Devireddy C, Lerakis S, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014;7:898–904.CrossRefPubMed

14.

Hayek SS, Corrigan FE 3rd, Condado JF, et al. Paravalvular regurgitation after transcatheter aortic valve replacement: comparing transthoracic versus transesophageal echocardiographic guidance. J Am Soc Echocardiogr. 2017;30:533–40.CrossRefPubMed

15.

Khalique OK, Hahn RT, Gada H, et al. Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2014;7:885–94.CrossRefPubMed

16.

Hansson NC, Norgaard BL, Barbanti M, et al. The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2015;9:382–92.CrossRefPubMed

17.

Baumgartner H, Hung J, Bermejo J, et al. Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: a Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30:372–92.CrossRefPubMed

18.

Piazza N, de Jaegere P, Schultz C, et al. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. 2008;1:74–81.CrossRefPubMed

19.

Kasel AM, Cassese S, Bleiziffer S, et al. Standardized imaging for aortic annular sizing: implications for transcatheter valve selection. JACC Cardiovasc Imaging. 2013;6:249–62.CrossRefPubMed

20.

Hahn RT, Nicoara A, Kapadia S, et al. Echocardiographic imaging for transcatheter aortic valve replacement. J Am Soc Echocardiogr. 2018;31:405–33.CrossRefPubMed

21.

Pontone G, Andreini D, Bartorelli AL, et al. Aortic annulus area assessment by multidetector computed tomography for predicting paravalvular regurgitation in patients undergoing balloon-expandable transcatheter aortic valve implantation: a comparison with transthoracic and transesophageal echocardiography. Am Heart J. 2012;164:576–84.CrossRefPubMed

22.

Tsang JF, Lytwyn M, Farag A, et al. Multimodality imaging of aortic dimensions: comparison of transthoracic echocardiography with multidetector row computed tomography. Echocardiography. 2012;29:735–41.CrossRefPubMed

23.

Tsuneyoshi H, Komiya T, Shimamoto T. Accuracy of aortic annulus diameter Measurement: comparison of multi-detector CT, two- and three-dimensional echocardiography. J Card Surg. 2016;31:18–22.CrossRefPubMed

24.

Husser O, Holzamer A, Resch M, et al. Prosthesis sizing for transcatheter aortic valve implantation–comparison of three dimensional transesophageal echocardiography with multislice computed tomography. Int J Cardiol. 2013;168:3431–8.CrossRefPubMed

25.

Janosi RA, Plicht B, Kahlert P, et al. Quantitative analysis of aortic valve stenosis and aortic root dimensions by three-dimensional echocardiography in patients scheduled for transcutaneous aortic valve implantation. Curr Cardiovasc Imaging Rep. United States2014:9296.

26.

Jilaihawi H, Doctor N, Kashif M, et al. Aortic annular sizing for transcatheter aortic valve replacement using cross-sectional 3-dimensional transesophageal echocardiography. J Am Coll Cardiol. 2013;61:908–16.CrossRefPubMed

27.

Khalique OK, Kodali SK, Paradis JM, et al. Aortic annular sizing using a novel 3-dimensional echocardiographic method: use and comparison with cardiac computed tomography. Circ Cardiovasc Imaging. 2014;7:155–63.CrossRefPubMed

28.

Tamborini G, Fusini L, Muratori M, et al. Feasibility and accuracy of three-dimensional transthoracic echocardiography vs. multidetector computed tomography in the evaluation of aortic valve annulus in patient candidates to transcatheter aortic valve implantation. Eur Heart J Cardiovasc. Imaging. 2014;15:1316–23.

29.

Attizzani GF, Ohno Y, Latib A, et al. Transcatheter aortic valve implantation under angiographic guidance with and without adjunctive transesophageal echocardiography. Am J Cardiol. 2015;116:604–11.CrossRefPubMed

30.

Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438–54.CrossRefPubMed

31.

Pibarot P, Hahn RT, Weissman NJ, et al. Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. JACC Cardiovasc Imaging. 2015;8:340–60.CrossRefPubMed

32.

Wendler O, Schymik G, Treede H, et al. SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve. Eur Heart J. 2017;38:2717–26.CrossRefPubMedPubMedCentral

33.

Auffret V, Lefevre T, Van Belle E, et al. Temporal trends in transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol. 2017;70:42–55.CrossRefPubMed

34.

Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61:1585–95.CrossRef

35.

Kodali S, Pibarot P, Douglas PS, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J. 2015;36:449–56.CrossRefPubMed

36.

Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299–308.CrossRef

37.

Zahn R, Gerckens U, Linke A, et al. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013;112:272–9.CrossRefPubMed

38.

Abdel-Wahab M, Zahn R, Horack M, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart. 2011;97:899–906.CrossRefPubMed

39.

Watanabe Y, Lefevre T, Arai T, et al. Can we predict postprocedural paravalvular leak after Edwards SAPIEN transcatheter aortic valve implantation? Catheter Cardiovasc Interv. 2015;86:144–51.CrossRefPubMed

40.

Abdel-Wahab M, Comberg T, Buttner HJ, et al. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. JACC Cardiovasc Interv. 2014;7:284–92.CrossRefPubMed

41.

Teeter EG, Dakik C, Cooter M, et al. Assessment of paravalvular leak after transcatheter aortic valve replacement: transesophageal echocardiography compared with transthoracic echocardiography. J Cardiothorac Vasc Anesth. 2017;31:1278–84.CrossRefPubMed

42.

Motloch LJ, Rottlaender D, Reda S, et al. Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol. 2012;101:45–53.CrossRefPubMed

43.

Yamamoto M, Meguro K, Mouillet G, et al. Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2013;111:94–9.CrossRefPubMed

44.

Frohlich GM, Lansky AJ, Webb J, et al. Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)–systematic review and meta-analysis. BMC Med. 2014;12:41.CrossRefPubMedPubMedCentral

45.

Sengupta PP, Wiley BM, Basnet S, et al. Transthoracic echocardiography guidance for TAVR under monitored anesthesia care. JACC Cardiovasc Imaging. 2015;8:379–80.CrossRefPubMed

46.

Jensen HA, Condado JF, Devireddy C, et al. Minimalist transcatheter aortic valve replacement: the new standard for surgeons and cardiologists using transfemoral access? J Thorac Cardiovasc Surg. 2015;150:833–9.CrossRefPubMed

47.

Attizzani GF, Alkhalil A, Padaliya B, et al. Comparison of outcomes of transfemoral transcatheter aortic valve implantation using a minimally invasive versus conventional strategy. Am J Cardiol. 2015;116:1731–6.CrossRefPubMed

48.

Oguri A, Yamamoto M, Mouillet G, et al. Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: subanalysis of the French Aortic National CoreValve and Edwards 2 registry. Circ Cardiovasc Interv. 2014;7:602–10.CrossRefPubMed

49.

Durand E, Borz B, Godin M, et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv. 2012;5:461–7.CrossRefPubMed

50.

Bergmann L, Kahlert P, Eggebrecht H, et al. Transfemoral aortic valve implantation under sedation and monitored anaesthetic care—a feasibility study. Anaesthesia. 2011;66:977–82.CrossRefPubMed

51.

Lauck SB, Wood DA, Achtem L, et al. Risk stratification and clinical pathways to optimize length of stay after transcatheter aortic valve replacement. Can J Cardiol. 2014;30:1583–7.CrossRefPubMed

52.

Lauck SB, Wood DA, Baumbusch J, et al. Vancouver transcatheter aortic valve replacement clinical pathway: minimalist approach, standardized care, and discharge criteria to reduce length of stay. Circ Cardiovasc Qual Outcomes. 2016;9:312–21.CrossRefPubMed

53.

Noad RL, Johnston N, McKinley A, et al. A pathway to earlier discharge following TAVI: assessment of safety and resource utilization. Catheter Cardiovasc Interv. 2016;87:134–42.CrossRefPubMed

54.

Serletis-Bizios A, Durand E, Cellier G, et al. A prospective analysis of early discharge after transfemoral transcatheter aortic valve implantation. Am J Cardiol. 2016;118:866–72.CrossRefPubMed

55.

Durand E, Eltchaninoff H, Canville A, et al. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis. Am J Cardiol. 2015;115:1116–22.CrossRefPubMed

56.

Carroll JD, Vemulapalli S, Dai D, et al. Procedural experience for transcatheter aortic valve replacement and relation to outcomes: the STS/ACC TVT registry. J Am Coll Cardiol. 2017;70:29–41.CrossRefPubMed

57.

Wassef AWA, Rodes-Cabau J, Liu Y, et al. The learning curve and annual procedure volume standards for optimum outcomes of transcatheter aortic valve replacement: findings from an international registry. JACC Cardiovasc Interv. 2018;11:1669–79.CrossRefPubMed

Title: The transition from transesophageal to transthoracic echocardiography during transcatheter aortic valve replacement: an evolving field
Authors: Menhel Kinno
Eric P. Cantey
Vera H. Rigolin
Publication date: 01-03-2019
Publisher: Springer Japan
Published in: Journal of Echocardiography / Issue 1/2019
Print ISSN: 1349-0222
Electronic ISSN: 1880-344X
DOI: https://doi.org/10.1007/s12574-018-0409-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The transition from transesophageal to transthoracic echocardiography during transcatheter aortic valve replacement: an evolving field

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Heart failure with recovered ejection fraction

Echocardiography-based pressure–volume loop assessment in the evaluation for the effects of indoxyl sulfate on cardiovascular function

Utility of strain imaging in conjunction with heart failure stage classification for heart failure patient management

Implications of detection of foramen ovale patent after cryptogenic ischemic stroke

Echocardiographic assessment of left ventricular systolic function

Nimura lecture: why are you evaluating RV function in patients with pulmonary arterial hypertension?